Antabuse in Severe Alcoholism: an Open Controlled Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00431262 |
Recruitment Status : Unknown
Verified March 2007 by Psykiatrisk Center Gentofte.
Recruitment status was: Recruiting
First Posted : February 5, 2007
Last Update Posted : March 5, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Alcoholism | Drug: antabuse (disulfiram) | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Antabuse in Severe Alcoholism: an Open Controlled Study |
Study Start Date : | February 2007 |
Study Completion Date : | June 2009 |

- The number of patients in each group who have not been drinking alcohol after 6 months of treatment.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Alcoholism
- Living in the departments catchment area
Exclusion Criteria:
- Pregnancy
- Schizophrenia
- Bipolar disorder
- Other substance abuse
- Dementia
- Anorexia

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00431262
Denmark | |
Psykiatrisk Center Gentofte | Recruiting |
Hellerup, Denmark, 2900 | |
Contact: Jakob Ulrichsen, MD, ph.d. (45) 3977 3650 jaul@geh.regionh.dk | |
Principal Investigator: Jakob Ulrichsen, MD, ph.d. |
Principal Investigator: | Jakob Ulrichsen, MD, ph.d. | Psykiatrisk Center Gentofte |
ClinicalTrials.gov Identifier: | NCT00431262 |
Other Study ID Numbers: |
EudraCT no. 2006-004921-27 |
First Posted: | February 5, 2007 Key Record Dates |
Last Update Posted: | March 5, 2007 |
Last Verified: | March 2007 |
alcoholism antabuse disulfiram abstinence cognitive behavioural therapy |
Alcoholism Alcohol-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |
Disulfiram Alcohol Deterrents Acetaldehyde Dehydrogenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |